Urgent Request for UK Atrial Fibrillation Patients to Contact NICE About Dronedarone
The Atrial Fibrillation Association in the UK was shocked by the decision by the National Institute for Health and Clinical Excellence (NICE) to deny atrial fibrillation patients access to dronedarone, a medication that has been approved in the U.S. and Europe. AFA is conducting a campaign to make the voices of atrial fibrillation patients heard. If you’re in the UK, and are as shocked as we are by NICE’s decision, please take action today.
Learn more about what you can do to influence NICE’s decision



